Prognostic value of serum albumin level in patients with diffuse large B cell lymphoma
Acta Biochimica Polonica · 05.12.2023
DOI: 10.18388/abp.2020_6171 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Biochimica Polonica, online erschienen am 05.12.2023. Verfasst von Liyan Chen und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast Surgery, Zhuhai Maternity and Child Health Hospital, Zhuhai, China; Fujian Medical University Union Hospital, Fujian, China. Hauptthemen laut MEDLINE: Lymphoma, Large B-Cell, Diffuse. Die Arbeit wurde bisher 4-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
To investigate the prognostic value of serum albumin (SA) levels before chemotherapy in patients with diffuse large B-cell lymphoma (DLBCL) after receiving chemotherapy.
Methods
This is a retrospective study, and 127 patients with DLBCL including 71 males (55.9%) and 56 females (44.1%) were included. Patients’ gender, age, Ann Arbor staging, eastern cooperative oncology group (ECOG) score, treatment options, international prognostic index, response rate, overall survival (OS), and progression-free survival (PFS) were obtained for statistical analysis.
Results
Univariate analysis showed that SA≤34 g/L, Ann Arbor III-IV, B symptoms, ECOG≥2, and bone marrow involvement suggest a poor prognosis in patients with DLBCL. Patients with persistent SA>34 g/L had significantly longer OS than patients with persistent SA≤34 g/L (P=0.020). Multivariate analysis showed that SA≤34 g/L (HR=0.48, 95% CI=0.26-0.90, P=0.022) and R-CHOP-like treatment regimen (HR=0.43, 95% CI=0.24-0.76, P=0.004) are independent factors that could affect the prognosis of patients with DLBCL.
Conclusion
SA can be used as an indicator of prognosis in patients with DLBCL before the first chemotherapy. DLBCL patients with SA≤34 g/L are associated with short OS and poor prognosis, which may potentially provide guidance for the clinician to pay more attention to this population before the first chemotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Breast Surgery, Zhuhai Maternity and Child Health Hospital, Zhuhai, China; Fujian Medical University Union Hospital, Fujian, China.
- Pediatric Hematology Department, Fujian Medical University Union Hospital, Fujian, China.
- Hematology Department, Fujian Medical University Union Hospital, Fujian, China.
Zitieren
APA
Chen, L., Pan, L., & Liu, T. (2023). Prognostic value of serum albumin level in patients with diffuse large B cell lymphoma. Acta Biochimica Polonica. https://doi.org/10.18388/abp.2020_6171
Vancouver
Chen L, Pan L, Liu T. Prognostic value of serum albumin level in patients with diffuse large B cell lymphoma. Acta Biochimica Polonica. 2023. doi:10.18388/abp.2020_6171
BibTeX
@article{Chen2023,
author = {Chen, Liyan and Pan, Lili and Liu, Tingbo},
title = {Prognostic value of serum albumin level in patients with diffuse large B cell lymphoma},
journal = {Acta Biochimica Polonica},
year = {2023},
doi = {10.18388/abp.2020_6171}
}
EUVIMED